TR200102605T2 - Monoterpen ketonları katkısı ihtiva eden nikotin içerikli TTS sistemleri (transdermaltedavi amaçlı sistemler) - Google Patents

Monoterpen ketonları katkısı ihtiva eden nikotin içerikli TTS sistemleri (transdermaltedavi amaçlı sistemler)

Info

Publication number
TR200102605T2
TR200102605T2 TR2001/02605T TR200102605T TR200102605T2 TR 200102605 T2 TR200102605 T2 TR 200102605T2 TR 2001/02605 T TR2001/02605 T TR 2001/02605T TR 200102605 T TR200102605 T TR 200102605T TR 200102605 T2 TR200102605 T2 TR 200102605T2
Authority
TR
Turkey
Prior art keywords
systems
nicotine
additives
transdermal treatment
monoterpene ketones
Prior art date
Application number
TR2001/02605T
Other languages
English (en)
Inventor
Bracht Stefan
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200102605T2 publication Critical patent/TR200102605T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Koruyucu bir tabakasi, en azindan bir adet nikotin ihtiva eden basinca duyarli yapiskanlik özelligine sahip olabilen en azindan bir adet nikotin ihtiva eden tabakasi, ve ayni zamanda sökülebilir koruyucu tabakasi bulunan bir transdermal terapötik sistem, ki bu sistem bir nane türünden çikartilan en az bir adet esansiyel yag yahut da bu esansiyel yaglar bünyesinde yer alan en azindan bir adet monoterpen ketonu ihtiva etmesi ile karaterizedir.
TR2001/02605T 1999-03-26 2000-03-21 Monoterpen ketonları katkısı ihtiva eden nikotin içerikli TTS sistemleri (transdermaltedavi amaçlı sistemler) TR200102605T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19913732A DE19913732A1 (de) 1999-03-26 1999-03-26 Nikotin-TTS mit einem Zusatz von Monoterpenketonen

Publications (1)

Publication Number Publication Date
TR200102605T2 true TR200102605T2 (tr) 2002-01-21

Family

ID=7902491

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02605T TR200102605T2 (tr) 1999-03-26 2000-03-21 Monoterpen ketonları katkısı ihtiva eden nikotin içerikli TTS sistemleri (transdermaltedavi amaçlı sistemler)

Country Status (23)

Country Link
US (1) US7029692B1 (tr)
EP (1) EP1164996B1 (tr)
JP (1) JP4750282B2 (tr)
KR (1) KR100597802B1 (tr)
CN (1) CN1199623C (tr)
AR (1) AR027485A1 (tr)
AT (1) ATE252356T1 (tr)
AU (1) AU769656B2 (tr)
BR (1) BR0010515A (tr)
CA (1) CA2367615C (tr)
CZ (1) CZ300409B6 (tr)
DE (2) DE19913732A1 (tr)
DK (1) DK1164996T3 (tr)
ES (1) ES2211523T3 (tr)
HU (1) HUP0200189A3 (tr)
IL (1) IL145502A0 (tr)
NZ (1) NZ514423A (tr)
PT (1) PT1164996E (tr)
RU (1) RU2228740C2 (tr)
TR (1) TR200102605T2 (tr)
TW (1) TWI227666B (tr)
WO (1) WO2000057824A1 (tr)
ZA (1) ZA200107864B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
ATE355854T1 (de) * 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
PL1670433T3 (pl) 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
ES2499067T3 (es) 2005-10-13 2014-09-26 Nitto Denko Corporation Preparación transdérmica de nicotina y método de producción de la misma
NZ571460A (en) * 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
CN101264277B (zh) * 2008-04-16 2012-09-26 冯冲 一种控烟戒烟复方精油
EP2552245B1 (en) * 2010-03-26 2018-11-14 Philip Morris Products S.A. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
JP5730355B2 (ja) * 2013-07-24 2015-06-10 学校法人近畿大学 Ｃｙｐ２ａ１３阻害剤
JP6888974B2 (ja) * 2016-01-27 2021-06-18 学校法人近畿大学 Ｃｙｐ２ａ１３阻害活性を有する化合物及びｃｙｐ２ａ１３阻害剤
WO2019055880A2 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. METHOD OF ADMINISTRATION AND TREATMENT

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3559655A (en) * 1969-02-25 1971-02-02 Sutton Res Corp Oxidized cellulose substitute smoking material and method of making same
US4039653A (en) * 1974-01-23 1977-08-02 Defoney, Brenman, Mayes & Baron Long-acting articles for oral delivery and process
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH01157921A (ja) * 1987-12-15 1989-06-21 Tsumura & Co 二重盲検試験用製剤の製造方法
JPH01290608A (ja) * 1988-05-18 1989-11-22 Sunstar Inc 殺菌剤組成物
EP0356382B1 (de) * 1988-08-02 1994-02-16 Ciba-Geigy Ag Mehrschichtiges Pflaster
JP2905210B2 (ja) * 1989-01-23 1999-06-14 フロイント産業株式会社 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
JPH0748190B2 (ja) * 1990-01-22 1995-05-24 株式会社東芝 キャッシュメモリ内蔵マイクロプロセッサ
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
JPH06181972A (ja) * 1992-12-18 1994-07-05 Kanebo Ltd 煙草臭消臭剤
US5520924A (en) * 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
JPH07133490A (ja) * 1993-11-10 1995-05-23 Pola Chem Ind Inc 消臭剤
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
JPH09110680A (ja) * 1995-10-19 1997-04-28 Yuutoku Yakuhin Kogyo Kk 皮膚炎治療貼付剤
JPH10130118A (ja) * 1996-10-25 1998-05-19 Lion Corp 外用剤組成物
JPH10306030A (ja) * 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd 外用剤組成物

Also Published As

Publication number Publication date
CN1199623C (zh) 2005-05-04
HUP0200189A2 (hu) 2002-05-29
ES2211523T3 (es) 2004-07-16
IL145502A0 (en) 2002-06-30
BR0010515A (pt) 2003-07-22
CA2367615A1 (en) 2000-10-05
CN1345213A (zh) 2002-04-17
CA2367615C (en) 2009-10-13
DE50004156D1 (de) 2003-11-27
PL351313A1 (en) 2003-04-07
US7029692B1 (en) 2006-04-18
JP4750282B2 (ja) 2011-08-17
EP1164996A1 (de) 2002-01-02
ATE252356T1 (de) 2003-11-15
CZ20013457A3 (cs) 2002-03-13
HUP0200189A3 (en) 2011-02-28
EP1164996B1 (de) 2003-10-22
PT1164996E (pt) 2004-03-31
KR100597802B1 (ko) 2006-07-10
JP2002540125A (ja) 2002-11-26
WO2000057824A1 (de) 2000-10-05
AU3813400A (en) 2000-10-16
AR027485A1 (es) 2003-04-02
RU2228740C2 (ru) 2004-05-20
ZA200107864B (en) 2002-11-27
TWI227666B (en) 2005-02-11
CZ300409B6 (cs) 2009-05-13
NZ514423A (en) 2003-08-29
DK1164996T3 (da) 2004-02-16
AU769656B2 (en) 2004-01-29
KR20010112366A (ko) 2001-12-20
DE19913732A1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
TR200102605T2 (tr) Monoterpen ketonları katkısı ihtiva eden nikotin içerikli TTS sistemleri (transdermaltedavi amaçlı sistemler)
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
CY1106411T1 (el) Διαδepμικο θepαπευτικο συστημα με fentanyl
DE122005000013I1 (de) Triacetin zur Erhöhung der transdermalen Penetration.
BR9609137B1 (pt) dispositivo para liberação de eletrotransporte transdérmico de fentanil e sufentanil.
DK1280541T4 (da) Anvendelse af hydrogenotrofe, acetogene stammer til forebyggelse eller behandling af fordøjelsesforstyrrelser
ATE322270T1 (de) Arzneimittel auf basis von gestagenen zur dermalen anwendung enthaltend ascorbinsäure sowie deren salze
DE60135104D1 (de) Mittel zum falschungssicheren von einem substrat
DE69719987T2 (de) Verfahren und vorrichtung zum vernichten von objekten
MXPA03011825A (es) Combinacion de ingrediente activo para tratar una dependencia de sustancias aditivas o narcoticas utilizando medicamentos.
ES2216630T3 (es) Metodos de tratar la hipertension dependiente de la sal.
NO20000336D0 (no) Anordning ved forankring av merd, teiner, bur o.l.
TR199802704T2 (tr) HIV tedavisinde Vx478, Zidovüdin, FTC ve/veya 3TC içeren kombinasyonlarin kullanimi.
CY1105620T1 (el) Περιεκτης για υποδερμικη συριγγα
BR0002546A (pt) Agente cosmético tópico contendo bezaldoximas
BR0108004A (pt) Método de aumento de estado de alerta por administração de um vomeroferina, e dispositivos de alarme de emissão de vomeroferina
IT1306257B1 (it) Dispositivo e metodo per la formazione e la fascettatura di gruppi difoglietti,in particolare banconote.
DK0889721T3 (da) Lægemiddel til udvendig anvendelse og anvendelse af en vandig oliesmulsion til et sådant lægemiddel
TR199802703T2 (tr) HIV tedavisinde Vx478, Zidovüdin, ve/veya 1592U89 içeren kombinasyonlarin kullanimi.
DK0749620T3 (da) Tyverisikret bogomslag/papbind m.v. til bøger
FR2654446B1 (fr) Moyen, papier et document de securite contre la falsification par agent chimique et la contrefacon.
DE29806117U1 (de) Vorrichtung zur Einführung von Leitungen in Gebäude, Schächte o.dgl.
DE29810404U1 (de) Lagerung von Druckrollen, Walzen o.dgl.
ATA208198A (de) Vorrichtung zum umblättern der seiten von büchern, notenheften u. dgl.
DE29805697U1 (de) Verschlußvorrichtung für Öffnungen von Gebäuden, Möbeln o.dgl.